AMN Healthcare Services Inc: Form 10-Q for the period ended Mar 31, 2018
Filed with the SEC on May 4, 2018 and accepted by EDGAR at May 4, 2018, 17:22 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2018-01-01 to 2018-03-31 | $354.7m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2018-01-01 to 2018-03-31 | $167.8m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2018-01-01 to 2018-03-31 | $104.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2018-01-01 to 2018-03-31 | $55.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2018-01-01 to 2018-03-31 | $5.3m | us-gaap:InterestExpense |
| Income tax | 3 months2018-01-01 to 2018-03-31 | $7.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2018-01-01 to 2018-03-31 | $42.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-01-01 to 2018-03-31 | $0.87 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2018-01-01 to 2018-03-31 | $0.89 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2018-01-01 to 2018-03-31 | 49,116,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2018-01-01 to 2018-03-31 | $59.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2018-01-01 to 2018-03-31 | $5.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2018-03-31 | $54.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-03-31 | $489.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-03-31 | $1.27bn | us-gaap:Assets |
| Current liabilities | At period end2018-03-31 | $251.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-03-31 | $673.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2018-03-31 | $599.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001142750-18-000007. Last ingested by Listed: Nov 5, 2026, 17:59 ET. Listed shows no prices and gives no investment advice.